Polycystic Ovary Syndrome (PCOS) & Unani Management
PCOS Overview Endocrine disorder in women (of reproductive age), characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Prevalence: Affects 5-20% of women globally, depending on diagnostic criteria. Etiology: Multifactorial (genetic, lifestyle environmental ) involves insulin resistance, elevated androgens, and hypothalamic-pituitary-ovarian axis disruption. Symptoms : Irregular menses, amenorrhea, Hirsutism, acne, alopecia, Infertility (anovulation), Obesity, insulin resistance, dyslipidemia, anxiety or depression. Diagnosis (Rotterdam criteria, 2003): Two of the following: Oligo-/anovulation. Clinical/biochemical hyperandrogenism. Polycystic ovaries on USG Complications : Infertility, pregnancy complications. Endometrial cancer risk. Cardiovascular and metabolic disorders. Conventional Management : Lifestyle changes (diet, exercise, weight loss). Medications: Oral contraceptives, metformin, clomiphene. Psychological support. Unani Philosophy and Manage...